AIM ImmunoTech Inc.
AIM
$1.21
$0.021.26%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.00K | 25.00K | 16.00K | 45.00K | 35.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.00K | 25.00K | 16.00K | 45.00K | 35.00K |
| Cost of Revenue | 68.00K | 10.00K | 10.00K | 7.00K | 8.00K |
| Gross Profit | -42.00K | 15.00K | 6.00K | 38.00K | 27.00K |
| SG&A Expenses | 1.80M | 1.49M | 2.65M | 4.32M | 3.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.47M | 2.67M | 3.64M | 5.90M | 4.52M |
| Operating Income | -2.45M | -2.65M | -3.62M | -5.86M | -4.49M |
| Income Before Tax | -3.28M | -2.79M | -3.71M | -5.97M | -3.70M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.28M | -2.79M | -3.71M | -5.97M | -3.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.28M | -2.79M | -3.71M | -5.97M | -3.70M |
| EBIT | -2.45M | -2.65M | -3.62M | -5.86M | -4.49M |
| EBITDA | -2.39M | -2.59M | -3.56M | -5.79M | -4.43M |
| EPS Basic | -1.57 | -3.68 | -5.26 | -9.31 | -6.41 |
| Normalized Basic EPS | -0.98 | -2.29 | -3.31 | -5.64 | -4.30 |
| EPS Diluted | -1.57 | -3.68 | -5.26 | -9.31 | -6.41 |
| Normalized Diluted EPS | -0.98 | -2.29 | -3.31 | -5.64 | -4.30 |
| Average Basic Shares Outstanding | 2.10M | 760.00K | 704.00K | 640.80K | 577.30K |
| Average Diluted Shares Outstanding | 2.10M | 760.00K | 704.00K | 640.80K | 577.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |